Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-28

Clinical Trial Update: Role of Alphacalcidol Supplement to Reduce Pain and COMP in Geriatric Knee Osteoarthritis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating alphacalcidol supplementation to reduce pain and Chartered something? COMP in geriatric knee osteoarthritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alphacalcidol (alphacalcidol)

Snippet

Sponsor: Syarif Hidayatullah State Islamic University Jakarta | Conditions: Osteoarthritis, Knee, Aged | Phase 3 | Status: COMPLETED